全文获取类型
收费全文 | 4840篇 |
免费 | 159篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 100篇 |
妇产科学 | 114篇 |
基础医学 | 630篇 |
口腔科学 | 45篇 |
临床医学 | 810篇 |
内科学 | 506篇 |
皮肤病学 | 42篇 |
神经病学 | 364篇 |
特种医学 | 223篇 |
外国民族医学 | 1篇 |
外科学 | 419篇 |
综合类 | 142篇 |
一般理论 | 14篇 |
预防医学 | 477篇 |
眼科学 | 419篇 |
药学 | 388篇 |
中国医学 | 88篇 |
肿瘤学 | 238篇 |
出版年
2024年 | 3篇 |
2023年 | 91篇 |
2022年 | 101篇 |
2021年 | 151篇 |
2020年 | 120篇 |
2019年 | 82篇 |
2018年 | 111篇 |
2017年 | 116篇 |
2016年 | 132篇 |
2015年 | 126篇 |
2014年 | 303篇 |
2013年 | 217篇 |
2012年 | 226篇 |
2011年 | 278篇 |
2010年 | 198篇 |
2009年 | 184篇 |
2008年 | 246篇 |
2007年 | 266篇 |
2006年 | 253篇 |
2005年 | 218篇 |
2004年 | 255篇 |
2003年 | 243篇 |
2002年 | 187篇 |
2001年 | 180篇 |
2000年 | 147篇 |
1999年 | 129篇 |
1998年 | 71篇 |
1997年 | 49篇 |
1996年 | 52篇 |
1995年 | 40篇 |
1994年 | 22篇 |
1993年 | 21篇 |
1992年 | 42篇 |
1991年 | 39篇 |
1990年 | 26篇 |
1989年 | 36篇 |
1988年 | 37篇 |
1987年 | 8篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有5036条查询结果,搜索用时 15 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(6):849-855
The emergence of carbapenem-resistant organisms posed considerable threat to global health while only limited treatment options are available and led to efforts to discover a novel way to treat them. To evaluate in vitro synergistic activity of meropenem plus ertapenem, a total of 203 carbapenem-resistant strains, collected from 12 provinces and municipalities in China, were examined with a dual carbapenem combination therapy. The statistical software R was used for analysis. Two hundred and one (201) of carbapenem-resistant strains mainly produced four types of carbapenemase: KPC-2 (n = 142, 69.95%), OXA-232 (n = 7, 3.45%), NDM (n = 38, 18.72%; 36 NDM-1, 1 NDM-4, 1 NDM-5), and IMP (n = 15, 7.39%; 1 IMP-26, 10 IMP-30, 4 IMP-4). Fifty-one out of two hundred and three (51/203 or 25.12%) of the examined strains showed a synergistic effect for the meropenem plus ertapenem combination throughout the checkerboard method, while only three isolates showed potential clinically relevant synergy (3/203, 1.48%). An additive effect was observed in 55/203 (27.09%) of the examined strains. Ninety-seven of the examined isolates (47.78%) showed fractional inhibitory concentration (FIC) greater or equal to 2 (indicating antagonism). The synergistic activity of meropenem plus ertapenem combination suggests this combination can be a possible way to treat the infection caused by the carbapenem-resistant organisms, especially for IMP or NDM producer with a lesser minimum inhibitory concentration (MIC) and the infected individual who was not recommended to use colistin or tigecycline. 相似文献
2.
《Geriatric nursing (New York, N.Y.)》2021,42(6):1569-1576
This study aimed to identify different trajectories of adherence to home rehabilitation for older adults with hip fracture and cognitive impairment, to examine associations between different adherence trajectories and postoperative recovery outcomes, and to explore the predictors of adherence trajectories. Group-based trajectory modeling showed two adherence trajectories: low (39.06%) and high (60.94%) adherence. The high adherence group had better activities of daily living (β=11.77, p<.001), instrumental activities of daily living (β=0.56, p<.01), femoral muscular strength (β=3.35, p<.01) on the fractured side and quality of life (β=-0.81, p=.02) than the low adherence group. Participants who established exercise habits (OR=6.49, p<.01) and consulted a physical therapist (OR=4.29, p=.03) during hospitalization were more likely to be in the high adherence group. 相似文献
3.
4.
Ngai-Yin Chan Chi-Chung Choy Ho-Chuen Yuen Hoi-Fan Chow Ho-Fai Fong 《The Canadian journal of cardiology》2019,35(4):396-404
Background
Persistent iatrogenic atrial septal defect (iASD) is a common but poorly characterized complication after cryoballoon (CB) pulmonary vein isolation (PVI) procedures. We therefore investigate its prevalence, evolution, risk factors, and clinical outcomes in a prospective longitudinal study.Methods
A total of 108 patients (41 women, mean age 57 ± 11.3) underwent CB PVI for AF. Serial transesophageal echocardiography (TEE) was performed 9 months and then annually until 6 years after the procedure to study the characteristics of persistent iASD.Results
Persistent iASD occurred in 33 (30.6%) patients 9 months after CB PVI. Spontaneous closure of iASD was found in 6 (22.2%) and 3 (15.8%) patients 2 and 3 years after the procedures, respectively. No spontaneous closure was observed on 4, 5, and 6-year TEE follow-up. The projected long-term persistence rate of iASD after CB PVI was therefore 20% (30.6% × 0.778 × 0.842). Using multivariate logistic regression, a higher number of cryoapplications (≥ 2 minutes) was the only independent predictor of persistent iASD 9 months after CB PVI (odds ratio [OR] 1.207; 95% confidence interval [CI], 1.033-1.411, P = 0.018). Two (1.9%) patients with significantly larger iASD size than the others (long diameter 12.6 ± 0.8 vs 3.7 ± 1.5 mm, P < 0.001; short diameter 10.9 ± 0.2 vs 3 ± 1.1 mm, P < 0.001) required percutaneous closure because of exertional dyspnea and right ventricular enlargement. Over 129.7 patient-years follow-up, during which iASD persisted, there was no occurrence of neurologic events.Conclusions
Approximately one fifth of patients undergoing CB PVI will have permanently persistent iASD. Patients with defect sizes of greater than 10 mm may need percutaneous closure due to significant left-to-right shunting. 相似文献5.
6.
Vincent Chung Liang Liu Zhaoxiang Bian Zhongzhen Zhao Wai Leuk Fong Wan Fung Kum Jing Gao Min Li 《Movement disorders》2006,21(10):1709-1715
The objective of this study is to assess the efficacy and safety of herbal medicines (HMs), as a monotherapy or adjunct therapy, compared to placebo or conventional approaches in the treatment of idiopathic Parkinson's disease (PD). We conducted a systematic review of randomized controlled trials from both conventional and alternative medicine sources. Outcome measures were overall improvement, quality of life, reduction of levodopa dose, and adverse events. Nine studies were included, each testing a different HM. Six of the trials had limited internal validity due to major flaws in design, including the lack of proper randomization; insufficient blinding; unclear inclusive criteria in terms of diagnostic criteria, baseline staging, and duration of disease; lack of proper sample size calculation; and insufficient data analysis. Imbalances in gender and ethnicity among the patients in the included trials were observed. No major adverse events emerged, and no specific pattern was detected from the trials describing such data. In addition to major methodological defects, heterogeneity in (1) HM tested, (2) control treatment, and (3) outcome measure hindered in-depth data analysis and synthesis. Current evidence is insufficient to evaluate the efficacy and safety of various HMs. Further studies with improved trial design and reporting, with assessment on cost-effectiveness, quality of life, and qualitative data are warranted. 相似文献
7.
9.
《Anaesthesia and Intensive Care Medicine》2007,8(11):468-470
Optimal management of the airway remains a cornerstone of critical care. However, several pathophysiological derangements exist in the critically ill, which may affect the choice of drugs and means of ventilation. Most patients who remain in the ICU for a prolonged period receive a tracheostomy, but no consensus exists for the optimal method of insertion, timing, or selection of patients who would benefit most from the procedure. Furthermore, although securing the airway by tracheal intubation is carried out for most patients, an expanding role exists for non-invasive ventilatory support. 相似文献
10.